Oryzon Genomics Eulerpool News

Oryzon Genomics Eulerpool News

Oryzon Genomics Aktie News

Oryzon Genomics wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Oryzon Genomics News stellen wir hier zusammen.

• 11. September ·

  Yahoo
  ORYZON Receives “Intention to Grant” Communication for Patent Relating to the Use of Vafidemstat in Borderline Personality Disorder
• 9. September ·

  Yahoo
  ORYZON Announces First Patient Dosed in an Investigator-Initiated Phase Ib Study of Iadademstat in First-Line Acute Myeloid Leukemia
• 3. September ·

  Yahoo
  ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat with Additional “Decision to Grant” Communications
• 29. August ·

  Yahoo
  ORYZON to Provide Corporate Progress Updates at Several Events in September
• 31. Juli ·

  Yahoo
  ORYZON reports financial results and corporate update for half-year ending June 30, 2024
• 8. Juli ·

  Yahoo
  ORYZON Receives “Decision to grant” for Two Important Patents for Vafidemstat in Japan
• 28. Juni ·

  Yahoo
  ORYZON Announces Voting Results from its 2024 Annual General Meeting of Shareholders
• 26. Juni ·

  Yahoo
  ORYZON Announces Presentation of Final Data From PORTICO, Vafidemstat’s Global Phase IIb Trial in Borderline Personality Disorder, at the 37th ECNP Annual Conference
• 14. Juni ·

  Yahoo
  ORYZON Presents Preliminary Data From Ongoing Phase Ib FRIDA Trial with Iadademstat Plus Gilteritinib in Relapsed/Refractory FLT3-mut AML Patients at EHA-2024
• 3. Juni ·

  Yahoo
  ORYZON Announces Journal Publication of Final Phase IIa ALICE Results with Iadademstat in The Lancet Hematology